The vaccine, called SurVaxM, aims to prevent the recurrence of glioblastoma, an aggressive brain cancer with few major advances in treatment.
Hosted on MSN
Brain cancer breakthrough as new immunotherapy drug that shrinks tumours shows 'promising results'
A groundbreaking immunotherapy treatment could help push the deadliest form of brain cancer into remission, a study suggests. Researchers in London and Canada have found that a new CAR-T cell therapy ...
WSW, NY, September 25th, 2026, FinanceWireThree months ago, Nuvectis Pharma (NASDAQ: NVCT) was an oncology developer ...
The Independent and Yahoo will earn a commission from purchases made via links in this article. Pricing and availability are subject to change. A novel immunotherapy could lead to a brain cancer ...
Metastasis, the process by which a tumor spreads throughout the body, is associated with the majority of cancer deaths.
A cutting-edge immunotherapy could help kids fight — and even banish — brain tumors, the leading cause of cancer-related deaths in children. The new treatment falls under a category called T-cell ...
For patients facing cancer, progress ultimately comes down to a deeply personal question: Can treatment give them more time? A series of developments reported during 2026 is providing new reasons for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results